Market Overview:
The global liquid-based needle free injector market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for needle-free injections and rising prevalence of chronic diseases. In addition, technological advancements in liquid-based needle free injectors are also contributing to the growth of this market. Based on type, the global liquid-based needle free injector market is segmented into jet, spring, laser, and vibration types. The jet type segment is expected to account for the largest share of the global liquid-based needle free injector market in 2018.
Product Definition:
Liquid-based needle free injectors are devices that use a pressurized liquid to deliver medication through the skin without the use of a needle. This type of device is often used to administer vaccines or other medications to large numbers of people in a short period of time. The importance of liquid-based needle free injectors lies in their ability to provide an efficient and safe means of delivering medication without the risk associated with needles.
Jet:
Jet is a needle-free injector which uses a stream of liquid to inject the drug into the vein. It's an improvement over traditional hypodermic injection as it requires no sharp or disposable needles, and offers greater safety along with reduced risk of needlestick injuries.
The product has been approved by the U.
Spring:
The global Spring and it’s usage in Liquid-based Needle Free Injector market size was valued at USD 6.5 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of7.1% from 2019 to 2025.
Application Insights:
Based on the application, the global market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This high share is attributable to a large patient base that necessitates injections on a regular basis for various diseases such as diabetes and anaphylaxis. Moreover, increasing investments by governments for developing healthcare infrastructure coupled with rising awareness about LNFIs are some of the factors responsible for this segment¢â‚¬â„¢s dominance over other applications globally.
The others application category includes corporate wellness centers, home care settings and veterinary clinics among others places where patients require injections but do not have access to medical facilities or practitioners skilled in using liquid-based needle free injectors due to geographical locations or lack of accessibility due to financial constraints among other reasons.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing R&D investments by government and private organizations, high prevalence of chronic diseases requiring long-term treatment, and presence of major players in this region. Moreover, growing preference for these devices over traditional ones due to safety features offered by former is also driving the market growth.
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to factors such as improving healthcare infrastructure and rising awareness about advanced technologies among people especially healthcare professionals working in rural areas. In addition, economic development coupled with increase in disposable income will boost demand further over coming years which was not possible before because of lack of proper training regarding safer alternatives for needle stick injuries or cuts/burns that require immediate medical attention thus leading people prefer traditional methods resulting into increased incidence rate & mortality rate from blood-borne infections like HIV/AIDS & hepatitis B & C (needle stick injuries).
Growth Factors:
- Increasing demand for needle-free injections owing to the benefits associated with it over traditional injections
- Rising prevalence of chronic diseases that require regular injection treatment, such as diabetes and cancer
- Technological advancements in liquid-based needle free injector devices that offer enhanced accuracy and precision
- Growing number of private and public sector initiatives to promote the use of needle-free injections as a safe and effective mode of medication delivery
- Rising awareness about the benefits of using liquid-based needle free injectors among healthcare professionals and patients
Scope Of The Report
Report Attributes
Report Details
Report Title
Liquid-based Needle Free Injector Market Research Report
By Type
Jet, Spring, Laser, Vibration
By Application
Hospital, Clinic, Others
By Companies
Antares Pharma, Bioject Medical Technologies, Medical International Technology, Endo International, National Medical Products, Valeritas, European Pharma Group, Crossject SA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Liquid-based Needle Free Injector Market Report Segments:
The global Liquid-based Needle Free Injector market is segmented on the basis of:
Types
Jet, Spring, Laser, Vibration
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Antares Pharma
- Bioject Medical Technologies
- Medical International Technology
- Endo International
- National Medical Products
- Valeritas
- European Pharma Group
- Crossject SA
Highlights of The Liquid-based Needle Free Injector Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Jet
- Spring
- Laser
- Vibration
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liquid-based Needle Free Injector Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Liquid-based needle free injectors are devices that use a liquid to dispense the medication. This type of injector is less likely to cause skin irritation than traditional needles.
Some of the major players in the liquid-based needle free injector market are Antares Pharma, Bioject Medical Technologies, Medical International Technology, Endo International, National Medical Products, Valeritas, European Pharma Group, Crossject SA.
The liquid-based needle free injector market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Liquid-based Needle Free Injector Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Liquid-based Needle Free Injector Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Liquid-based Needle Free Injector Market - Supply Chain
4.5. Global Liquid-based Needle Free Injector Market Forecast
4.5.1. Liquid-based Needle Free Injector Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Liquid-based Needle Free Injector Market Size (000 Units) and Y-o-Y Growth
4.5.3. Liquid-based Needle Free Injector Market Absolute $ Opportunity
5. Global Liquid-based Needle Free Injector Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Liquid-based Needle Free Injector Market Size and Volume Forecast by Type
5.3.1. Jet
5.3.2. Spring
5.3.3. Laser
5.3.4. Vibration
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Liquid-based Needle Free Injector Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Liquid-based Needle Free Injector Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Liquid-based Needle Free Injector Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Liquid-based Needle Free Injector Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Liquid-based Needle Free Injector Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Liquid-based Needle Free Injector Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Liquid-based Needle Free Injector Demand Share Forecast, 2019-2026
9. North America Liquid-based Needle Free Injector Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Liquid-based Needle Free Injector Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Liquid-based Needle Free Injector Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Liquid-based Needle Free Injector Market Size and Volume Forecast by Type
9.7.1. Jet
9.7.2. Spring
9.7.3. Laser
9.7.4. Vibration
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Liquid-based Needle Free Injector Demand Share Forecast, 2019-2026
10. Latin America Liquid-based Needle Free Injector Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Liquid-based Needle Free Injector Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Liquid-based Needle Free Injector Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Liquid-based Needle Free Injector Market Size and Volume Forecast by Type
10.7.1. Jet
10.7.2. Spring
10.7.3. Laser
10.7.4. Vibration
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Liquid-based Needle Free Injector Demand Share Forecast, 2019-2026
11. Europe Liquid-based Needle Free Injector Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Liquid-based Needle Free Injector Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Liquid-based Needle Free Injector Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Liquid-based Needle Free Injector Market Size and Volume Forecast by Type
11.7.1. Jet
11.7.2. Spring
11.7.3. Laser
11.7.4. Vibration
11.8. Basis Poin Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Liquid-based Needle Free Injector Demand Share, 2019-2026
12. Asia Pacific Liquid-based Needle Free Injector Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Liquid-based Needle Free Injector Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Liquid-based Needle Free Injector Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Liquid-based Needle Free Injector Market Size and Volume Forecast by Type
12.7.1. Jet
12.7.2. Spring
12.7.3. Laser
12.7.4. Vibration
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Liquid-based Needle Free Injector Demand Share, 2019-2026
13. Middle East & Africa Liquid-based Needle Free Injector Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Liquid-based Needle Free Injector Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Liquid-based Needle Free Injector Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Liquid-based Needle Free Injector Market Size and Volume Forecast by Type
13.7.1. Jet
13.7.2. Spring
13.7.3. Laser
13.7.4. Vibration
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Liquid-based Needle Free Injector Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Liquid-based Needle Free Injector Market: Market Share Analysis
14.2. Liquid-based Needle Free Injector Distributors and Customers
14.3. Liquid-based Needle Free Injector Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Antares Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bioject Medical Technologies
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medical International Technology
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Endo International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. National Medical Products
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Valeritas
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. European Pharma Group
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Crossject SA
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook